Effects of HMG CoA Reductase Inhibitors on Cholesterol Synthesis

This publication has 29 references indexed in Scilit:

• Discovery, biochemistry and biology of lovastatin
  The American Journal of Cardiology, 1988
• A Receptor-Mediated Pathway for Cholesterol Homeostasis
  Science, 1986
• Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
  Proceedings of the National Academy of Sciences, 1980
• The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme—A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks
  Atherosclerosis, 1980
• Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.
  The Journal of Antibiotics, 1979
• SPECIFIC INHIBITION OF DESMOSTEROL SYNTHESIS BY ML-236B IN MOUSE LM CELLS GROWN IN SUSPENSION IN A LIPID-FREE MEDIUM
  Japanese Journal of Medical Science and Biology, 1978
• Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase
  European Journal of Biochemistry, 1977
• Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
  FEBS Letters, 1976
• ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
  The Journal of Antibiotics, 1976